SANUWAVE Health (SNWV) Capital Leases (2011 - 2025)
SANUWAVE Health (SNWV) reported Capital Leases of $11000.0 for Q2 2025, down 83.33% on a QoQ basis from $66000.0 in Q4 2024.
SANUWAVE Health (SNWV) has 7 years of Capital Leases data on file, last reported at $11000.0 in Q2 2025.
- Quarterly Capital Leases changed N/A year-over-year to $11000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $11000.0 (changed N/A YoY) and the FY2024 annual result came in at $66000.0, changed N/A from the prior year.
- Capital Leases slipped to $11000.0 in Q2 2025 per SNWV's latest filing, from $66000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $66000.0 in Q4 2024 and bottomed at $11000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SANUWAVE Health | 137.37 Mn | 126.59 Mn | 7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 11,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Dec 31, 2020 | 233,766.00 |
| Sep 30, 2020 | 284,588.00 |
| Jun 30, 2020 | 333,771.00 |
| Mar 31, 2020 | 332,641.00 |
| Dec 31, 2019 | 271,240.00 |
| Dec 31, 2013 | 3,951.00 |
| Jun 30, 2013 | 1,343.00 |
| Mar 31, 2013 | 2,659.00 |
| Dec 31, 2012 | 3,951.00 |
| Sep 30, 2012 | 5,220.00 |
| Jun 30, 2012 | 6,464.00 |
| Mar 31, 2012 | 7,685.00 |
| Dec 31, 2011 | 8,884.00 |